首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   420219篇
  免费   23376篇
  国内免费   1850篇
耳鼻咽喉   5271篇
儿科学   11971篇
妇产科学   9577篇
基础医学   58000篇
口腔科学   12090篇
临床医学   31590篇
内科学   93515篇
皮肤病学   10542篇
神经病学   36693篇
特种医学   13353篇
外国民族医学   54篇
外科学   57515篇
综合类   3602篇
一般理论   278篇
预防医学   36734篇
眼科学   8767篇
药学   30502篇
  3篇
中国医学   1531篇
肿瘤学   23857篇
  2023年   2203篇
  2022年   3627篇
  2021年   9444篇
  2020年   5338篇
  2019年   8917篇
  2018年   11766篇
  2017年   7948篇
  2016年   8300篇
  2015年   9317篇
  2014年   12377篇
  2013年   17438篇
  2012年   26212篇
  2011年   27148篇
  2010年   15234篇
  2009年   12928篇
  2008年   22750篇
  2007年   23410篇
  2006年   22581篇
  2005年   21868篇
  2004年   20697篇
  2003年   19474篇
  2002年   18503篇
  2001年   11061篇
  2000年   11413篇
  1999年   9540篇
  1998年   3586篇
  1997年   2705篇
  1996年   2448篇
  1995年   2265篇
  1994年   1910篇
  1993年   1820篇
  1992年   5249篇
  1991年   4948篇
  1990年   4615篇
  1989年   4183篇
  1988年   3907篇
  1987年   3590篇
  1986年   3599篇
  1985年   3336篇
  1984年   2613篇
  1983年   2304篇
  1979年   2313篇
  1978年   1687篇
  1975年   1727篇
  1974年   2054篇
  1973年   2034篇
  1972年   1892篇
  1971年   1805篇
  1969年   1723篇
  1968年   1680篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
2.
3.
Intratumor heterogeneity is a main cause of the dismal prognosis of glioblastoma (GBM). Yet, there remains a lack of a uniform assessment of the degree of heterogeneity. With a multiscale approach, we addressed the hypothesis that intratumor heterogeneity exists on different levels comprising traditional regional analyses, but also innovative methods including computer-assisted analysis of tumor morphology combined with epigenomic data. With this aim, 157 biopsies of 37 patients with therapy-naive IDH-wildtype GBM were analyzed regarding the intratumor variance of protein expression of glial marker GFAP, microglia marker Iba1 and proliferation marker Mib1. Hematoxylin and eosin stained slides were evaluated for tumor vascularization. For the estimation of pixel intensity and nuclear profiling, automated analysis was used. Additionally, DNA methylation profiling was conducted separately for the single biopsies. Scoring systems were established to integrate several parameters into one score for the four examined modalities of heterogeneity (regional, cellular, pixel-level and epigenomic). As a result, we could show that heterogeneity was detected in all four modalities. Furthermore, for the regional, cellular and epigenomic level, we confirmed the results of earlier studies stating that a higher degree of heterogeneity is associated with poorer overall survival. To integrate all modalities into one score, we designed a predictor of longer survival, which showed a highly significant separation regarding the OS. In conclusion, multiscale intratumor heterogeneity exists in glioblastoma and its degree has an impact on overall survival. In future studies, the implementation of a broadly feasible heterogeneity index should be considered.  相似文献   
4.
5.
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years.  相似文献   
6.
Journal of Immigrant and Minority Health - COVID-19 has disproportionally affected underrepresented minorities (URM) and low-income immigrants in the United States. The aim of the study is to...  相似文献   
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号